The Institute of Genetics and Cancer is a strategic partnership of the MRC Human Genetics Unit (HGU), Edinburgh Cancer Research, and the Centre for Genomic and Experimental Medicine that together form a coalition of distinct world class expertise in genetics and cancer.
The Institute of Genetics and Cancer is tackling one of the greatest biomedical challenges, determining how mutations – constitutional and acquired - drive the molecular and cellular dysfunction that result in disease. Defining the molecular mechanisms of genetic disease and cancer, and the flow of information from DNA through to the production and regulation of RNAs and proteins is critical to deliver pathways targetable by future therapies. Delivering this mission requires a critical mass of expertise to harness multiscale, multimodal and multidisciplinary approaches and research that scales from nanoscale to population; from biochemistry to in vivo; and from bedside to AI.
- Allele-specific protein complex assembly counteracts the dominant negative effect
- Shining a Light on Skin Cancer
- Life-saving cancer drug takes a major step closer to patient care
- Double testing better at identifying bowel cancer
- Boost for bowel cancer research in Scotland as first surgical research chair appointed
Distinguished scientists from around the world working in areas of genetics, molecular medicine and cancer relevant to our research. Student seminar blogs
Institute of Genetics and Cancer Twitter account.
Our multidisciplinary approach, researchers, collaborations and funding.
State of the art scientific facilities, infrastructure and business support.
Translating our research to maximise impact on human health.
Current vacancies and the benefits of being part of our community.
Postgraduate study opportunities, including PhDs and Masters programmes.
Explore our research, meet our researchers and discover how you can support us.